Teixeira-Farinha, Hugo
Béhal, Hélène
Cailliau, Emeline
Pasquer, Arnaud
Duhamel, Alain
Théréaux, Jérémie
Chalret du Rieu, Mael
Lefevre, Jérémie H.
Turner, Kathleen
Mantziari, Styliani
Collet, Denis
Piessen, Guillaume
Gronnier, Caroline
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Impact of primary endoscopic resection on oncological outcomes after esophagectomy for cancer: a retrospective propensity score-based cohort study
https://doi.org/10.1007/s00464-024-11077-2
Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study
https://doi.org/10.1016/j.ejca.2015.11.024
Article History
Received: 17 March 2024
Accepted: 8 July 2024
First Online: 22 July 2024
Declarations
:
: The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Hugo Teixeira-Farinha, Hélène Béhal, Emeline Cailliau, Arnaud Pasquer, Alain Duhamel, Jérémie Théréaux, Mael Chalret du Rieu, Jérémie Lefevre, Kathleen Turner, Styliani Mantziari, Denis Collet, Guillame Piessen, and Caroline Gronnier have no conflicts of interest or financial ties to disclose.
: In accordance with the Declaration of Helsinki and French regulations on clinical trials, approvals were obtained for all French participating centers from the following authorities: the Comité de Protection des Personnes (Ethics Committee) on 10 December 2013, the Agence Nationale de Sécurité du Médicament et des produits de santé (French Health Products Safety Agency) on 13 January 2014, the Comité Consultatif sur le Traitement de l’Information en Matière de Recherche dans le Domaine de la Santé (Advisory Committee on Processing Information Associated with Health Research) on 12 March 2014, and the Commission Nationale Informatique et Libertés (French Data Protection Authority) on 23 December 2014.